Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Familial Hypophosphatemic Rickets

• The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency
• The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency
• Prevention of Spontaneous Dental Abscesses in Children With X-linked Hypophosphatemia : a RCT
• Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLH
• Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLH
• Anti-FGF23 (Burosumab) in Adult Patients With XLH
• Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 Deficiency
• Burosumab in Children and Adolescents With X-linked Hypophosphatemia
• A Study of KRN23 in Adult and Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia
• Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of Age
• Examining the Effect of Burosumab on Muscle Function
• Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLH
• Using Different Doses of Active Vitamin D Combined With Neutral Phosphate in Children With X-linked Hypophosphatemia
• The Impact of Phosphate Metabolism on Healthy Aging
• Calcitriol Monotherapy for X-Linked Hypophosphatemia
• A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia
• Efficacy and Safety of Burosumab (KRN23) Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)
• Study of the Safety, Pharmacodynamics and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)
• Growth Hormone Treatment in Children With Hypophosphatemic Rickets
• Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)
• A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia
• Study of KRN23, a Recombinant Fully Human Monoclonal Antibody Against FGF23, in Pediatric Subjects With X-linked Hypophosphatemia (XLH)
• Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)
• Calcitonin for Treating X-linked Hypophosphatemia
• An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
• A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
• Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets
• Hypophosphatemic Rickets in Norway
• Calcimimetics in Hypophosphatemic Rickets
• A Study of KRN23 in X-linked Hypophosphatemia
• Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic Rickets
• Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets
• Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets